Price Move History
- Daily moves over 5%
- 1 5 sessions, January 29, 2026 to October 21, 2026
- Largest daily move
- +7.9% close of April 17, 2026
Company Description
Grifols SA (OTC: GIFOF) is classified in the drug manufacturers - general industry within the Healthcare sector and carries a market capitalization of $5.0B.
GIFOF gained 3.0% in the week to October 21, 2026. The last closing price was $7.29.
For FY2025, Grifols SA reported revenue of $8.8B with net income of $471.8M and diluted earnings per share of $0.69. The company operates at a net profit margin of 5.3%.
This page collects what Stock Titan holds for GIFOF, including price data, SEC filings, financial highlights, and short interest trends.
Stock Performance
Grifols SA (GIFOF) closed at $7.29 on October 21, 2026. In the week to October 21, 2026, the price gained 3.0%.
GIFOF Metrics & Rankings
Price returns through October 21, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
Grifols SA has filed 10 recent SEC filings, including 8 Form 6-K, 1 Form SCHEDULE 13G/A, 1 Form 20-F. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all GIFOF SEC filings →
Financial Highlights
Grifols SA generated $8.8B in revenue in FY2025, retaining a 38.0% gross margin, operating income reached $1.5B (16.5% operating margin), and net income was $471.8M, reflecting a 5.3% net profit margin. Diluted earnings per share stood at $0.69. The company generated $1.2B in operating cash flow. The current ratio was 2.51, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in Grifols SA (GIFOF) currently stands at 126.7 thousand shares, down 13.1% from the previous reporting period, representing 0.0% of the float. Since November 2025, short interest has increased by 360.9%.
Days to Cover History
Days to cover for Grifols SA (GIFOF) currently stands at 1000.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.
GIFOF Company Profile & Sector Positioning
Grifols SA (GIFOF) operates in the Drug Manufacturers - General industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing GIFOF often look at related companies in the same sector, including Ono Pharm Co (OPHLY), Hikma Pharms PLC (HKMPY), Hikma Pharmaceuticals PLC (HKMPF), CSPC Pharms Grp (CSPCY), and Sumitomo Pharma Co (SMDPY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate GIFOF's relative position within its industry.